Streetbeat News

Revenues

LEA

Lear Corporation's shares are experiencing a decline due to a reduction in their fiscal year 2024 net sales guidance.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 7:30 pm

PWOD

Penns Woods Bancorp reported Q3 revenue of $28.2 million and an adjusted EPS of $0.63 per share.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 7:24 pm

ASML

LRCX

Analysts from BofA Securities and Goldman Sachs have reiterated Buy ratings for Lam Research (NASDAQ:LRCX), highlighting its growth potential amid a NAND recovery and advanced packaging strength. Despite risks from China and export controls, Lam Research is expected to outperform competitors in 2025 due to its unique portfolio and market share gains in wafer fabrication equipment.

Portfolio Pulse from Nabaparna Bhattacharya

October 24, 2024 | 7:09 pm

PRG

In the last three months, analysts have shown a positive outlook on PROG Holdings (NYSE:PRG), with recent ratings indicating a bullish sentiment. The average 12-month price target has increased by 18.24% to $54.0. Despite challenges in revenue growth and net margin, the company shows strong ROE and ROA, and maintains a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:01 pm

PII

Polaris (NYSE:PII) has received mixed ratings from analysts over the past three months, with a recent decline in average price targets. Analysts have lowered their ratings and price targets, reflecting concerns over Polaris's recent revenue decline and high debt levels, despite strong net margins and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:01 pm

WGO

Winnebago Industries (NYSE:WGO) has received mixed analyst ratings, with a recent decrease in average price targets. Analysts have adjusted their ratings and price targets, reflecting a negative shift in sentiment. Despite challenges in revenue growth, Winnebago shows strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:00 pm

LUMO

Lumos Pharma (NASDAQ:LUMO) has been analyzed by 5 analysts, showing a range of ratings from bullish to bearish. Recent analyst actions include lowered price targets and ratings, with an average 12-month price target of $13.1, down from $23.00. The company faces financial challenges, including a decline in revenue growth and negative profitability metrics.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:00 pm

TSM

Taiwan Semiconductor (NYSE:TSM) has significantly outperformed the market over the past decade, with an average annual return of 24.81%. A $100 investment in TSM 10 years ago would now be worth $917.42, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:00 pm

TJX

TJX Companies (NYSE:TJX) has significantly outperformed the market over the past 15 years, with an annualized return of 18.16%. A $100 investment in TJX 15 years ago would now be worth $1,186.69. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:00 pm

MXL

Analysts have varied opinions on MaxLinear (NASDAQ:MXL), with recent ratings showing a shift towards bullish sentiment. The average 12-month price target has decreased by 18.4% to $20.67. MaxLinear faces financial challenges, including a significant revenue decline and low profitability metrics.

Portfolio Pulse from Benzinga Insights

October 24, 2024 | 7:00 pm